Journal
CLINICAL NUCLEAR MEDICINE
Volume 35, Issue 6, Pages 452-453Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0b013e3181db4ce9
Keywords
prostate cancer; fluorodeoxyglucose; positron emission tomography